IPSS questionnaire

OTHER4 trials

Sponsors

GlaxoSmithKline, Rabin Medical Center, Assaf-Harofeh Medical Center, University of Florence

Conditions

BRCA1 SyndromeBRCA2 SyndromeBenign Prostate EnlargementBladder DiseaseBladder Outlet ObstructionLynch SyndromeOveractive Bladder SyndromeProstatic Hyperplasia

Unknown Phase

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

CompletedNCT00316732

GlaxoSmithKlineProstatic Hyperplasia

Start: 2004-10-25End: 2006-12-19Updated: 2017-10-16

Prostate Cancer Screening Among Men With High Risk Genetic Predisposition

Rabin Medical CenterBRCA1 Syndrome, BRCA2 Syndrome, Lynch Syndrome

Start: 2014-02-28End: 2019-06-30Target: 200Updated: 2017-10-17

Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity

Assaf-Harofeh Medical CenterBenign Prostate Enlargement, Bladder Disease, Bladder Outlet Obstruction +2

Start: 2017-07-01End: 2020-08-19Target: 330Updated: 2020-04-21

COVID-19 (SARS-CoV-2) in Urine and Semen

CompletedNCT04446169

University of FlorenceSARS-CoV 2, Semen, Sexual Function and Fertility Disorders +2

Start: 2020-06-27End: 2021-09-02Updated: 2021-10-11

Related Papers

Imaging-based prostate cancer screening among BRCA mutation carriers—results from the first round of screening

Annals of Oncology2020-09-1847 citations

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.

2014-07-214 citations